ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CNTB vs HOWL // NET PROFIT MARGIN

Connect Biopharma Holdings Limited (NASDAQ) VS. Werewolf Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CNTB 0 — HOWL 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNTB VS. HOWL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CNTB HOWL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 HOWL /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 33.2 51.1 -17.95 HOWL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $52.6M $53.5M -$850.2K HOWL /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CNTB REV HOWL REV CNTB GROSS % HOWL GROSS % CNTB FCF HOWL FCF
FY 2025 $64.0K $0 — — -$51.6M -$60.3M
FY 2024 $26.0M $0 — — -$24.4M -$56.4M
FY 2023 $0 $0 — — -$47.7M -$32.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNTB // BETA —
HOWL // BETA —